Core Viewpoint - The company, Keqian Bio (688526), has announced a collaboration with Huazhong Agricultural University to develop four vaccine projects and related testing kits, with a total payment of 4.9 million yuan for the research and development efforts [1] Group 1 - The collaboration includes the development of a combined vaccine for canine diseases and two vaccines for swine diseases, along with an ELISA antibody testing kit for swine [1] - The total payment to Huazhong Agricultural University for the four research projects is 4.9 million yuan [1] - The intellectual property and technological achievements from the collaboration will be jointly owned by both the company and Huazhong Agricultural University [1]

Core Viewpoint - The company, Keqian Bio (688526.SH), has entered into a competitive negotiation with Huazhong Agricultural University to collaborate on the development of four vaccine and testing projects, indicating a strategic move to enhance its product offerings in the veterinary medicine sector [1] Group 1: Collaboration Details - The company will collaborate with Huazhong Agricultural University on the following projects: "Canine Distemper, Canine Parainfluenza, Canine Adenovirus and Canine Parvovirus Quadrivalent Live Vaccine - Inactivated Canine Coronavirus Vaccine," "Inactivated Porcine Gaiter Virus Vaccine," "ELISA Antibody Test Kit for Porcine Proliferative Enteropathy," and "NADC30-like Porcine Reproductive and Respiratory Syndrome Live Vaccine (GX2024 Strain)" [1] - The total payment to Huazhong Agricultural University for these four research and development projects will amount to 4.9 million RMB [1] - The technical achievements and intellectual property generated from the collaboration will be jointly owned by both the company and Huazhong Agricultural University [1]